Wallace Crandall

Summary

Affiliation: Nationwide Children's Hospital
Country: USA

Publications

  1. pmc Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease
    Wallace V Crandall
    Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children s Hospital, Columbus, OH 43205, USA
    Pediatrics 129:e1030-41. 2012
  2. doi request reprint Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease
    Wallace V Crandall
    Nationwide Children s Hospital, Columbus, Ohio 43205, USA
    Inflamm Bowel Dis 17:2184-91. 2011
  3. doi request reprint Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH
    Wallace Crandall
    Nationwide Children s Hospital, Columbus, OH 43205, USA
    J Pediatr Gastroenterol Nutr 49:183-90. 2009
  4. doi request reprint ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network
    Wallace Crandall
    Division of Pediatric Gastroenterology, Nationwide Children s Hospital, Columbus, Ohio 43205, USA
    Inflamm Bowel Dis 17:450-7. 2011
  5. doi request reprint Course and treatment of perianal disease in children newly diagnosed with Crohn's disease
    David J Keljo
    Pediatric Gastroenterology, Hepatology and Nutrition, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania 15213, USA
    Inflamm Bowel Dis 15:383-7. 2009
  6. doi request reprint Effect of early immunomodulator use in moderate to severe pediatric Crohn disease
    Jaya Punati
    Nationwide Children s Hospital, Ohio State University, Columbus, Ohio 43210, USA
    Inflamm Bowel Dis 14:949-54. 2008
  7. doi request reprint Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity
    Jennifer L Dotson
    Nationwide Children s Hospital, Columbus, OH 43205, USA
    J Pediatr Gastroenterol Nutr 51:140-5. 2010
  8. doi request reprint Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease
    Joel R Rosh
    Division of Pediatric Gastroenterology, Goryeb Children s Hospital Atlantic Health, Morristown, New Jersey 07962, USA
    Am J Gastroenterol 104:3042-9. 2009
  9. pmc Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?
    James Markowitz
    Division of Pediatric Gastroenterology, North Shore, LIJ Health System, New Hyde Park, New York, USA
    Inflamm Bowel Dis 15:714-9. 2009
  10. doi request reprint A single-center experience with methotrexate after thiopurine therapy in pediatric Crohn disease
    Brendan Boyle
    Department of Pediatrics, Division of Pediatric Gastroenterology, Nationwide Children s Hospital, Columbus, OH, USA
    J Pediatr Gastroenterol Nutr 51:714-7. 2010

Detail Information

Publications13

  1. pmc Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease
    Wallace V Crandall
    Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children s Hospital, Columbus, OH 43205, USA
    Pediatrics 129:e1030-41. 2012
    ..We sought to improve chronic care delivery and outcomes for children with inflammatory bowel disease by using network-based quality improvement methods...
  2. doi request reprint Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease
    Wallace V Crandall
    Nationwide Children s Hospital, Columbus, Ohio 43205, USA
    Inflamm Bowel Dis 17:2184-91. 2011
    ..This review describes the history, rationale, and methods of quality measurement and discusses the early work and lessons learned from measuring quality of care in a pediatric IBD quality improvement collaborative...
  3. doi request reprint Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH
    Wallace Crandall
    Nationwide Children s Hospital, Columbus, OH 43205, USA
    J Pediatr Gastroenterol Nutr 49:183-90. 2009
    ..Post hoc analyses evaluated the effect of infliximab upon concurrent perianal Crohn disease (CD) in a subpopulation of 31 patients from REACH, a randomized trial of 112 children with moderately to severely active luminal CD...
  4. doi request reprint ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network
    Wallace Crandall
    Division of Pediatric Gastroenterology, Nationwide Children s Hospital, Columbus, Ohio 43205, USA
    Inflamm Bowel Dis 17:450-7. 2011
    ..There is significant variation in diagnostic testing and treatment for inflammatory bowel disease. Quality improvement science methods can help address unwarranted variations in care and outcomes...
  5. doi request reprint Course and treatment of perianal disease in children newly diagnosed with Crohn's disease
    David J Keljo
    Pediatric Gastroenterology, Hepatology and Nutrition, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania 15213, USA
    Inflamm Bowel Dis 15:383-7. 2009
    ..We sought to characterize perianal disease and its treatment in pediatric patients newly diagnosed with Crohn's disease...
  6. doi request reprint Effect of early immunomodulator use in moderate to severe pediatric Crohn disease
    Jaya Punati
    Nationwide Children s Hospital, Ohio State University, Columbus, Ohio 43210, USA
    Inflamm Bowel Dis 14:949-54. 2008
    ..We describe IM use in newly diagnosed pediatric CD, comparing outcomes of "early" versus "late" initiation of therapy...
  7. doi request reprint Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity
    Jennifer L Dotson
    Nationwide Children s Hospital, Columbus, OH 43205, USA
    J Pediatr Gastroenterol Nutr 51:140-5. 2010
    ..The purpose of this study was to determine the rates of EIMs in pediatric IBD and examine correlations with age, sex, diagnosis, disease severity, and distribution...
  8. doi request reprint Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease
    Joel R Rosh
    Division of Pediatric Gastroenterology, Goryeb Children s Hospital Atlantic Health, Morristown, New Jersey 07962, USA
    Am J Gastroenterol 104:3042-9. 2009
    ..The aim of this study was to characterize common indications, safety, tolerability, and clinical response to adalimumab in pediatric CD in a large, multicenter, patient cohort...
  9. pmc Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?
    James Markowitz
    Division of Pediatric Gastroenterology, North Shore, LIJ Health System, New Hyde Park, New York, USA
    Inflamm Bowel Dis 15:714-9. 2009
    ..Differences in immune response may offer clues to the pathogenesis of the disease. The aim was to examine the influence of age at diagnosis on the serologic response in children with CD...
  10. doi request reprint A single-center experience with methotrexate after thiopurine therapy in pediatric Crohn disease
    Brendan Boyle
    Department of Pediatrics, Division of Pediatric Gastroenterology, Nationwide Children s Hospital, Columbus, OH, USA
    J Pediatr Gastroenterol Nutr 51:714-7. 2010
    ..Methotrexate (MTX) may be considered for those intolerant of or unresponsive to thiopurines. The purpose of this study was to examine the effectiveness of MTX as maintenance therapy in patients previously treated with thiopurines...
  11. doi request reprint Exploring the differential diagnosis of joint complaints in pediatric patients with inflammatory bowel disease
    Jennifer Dotson
    Division of Pediatric Gastroenterology, Nationwide Children s Hospital, 700 Children s Drive, Columbus, OH 43205, USA
    Curr Gastroenterol Rep 13:271-8. 2011
    ..We explore the differential diagnosis of joint complaints in children, with a focus on IBD-related disease and rheumatic disease...
  12. doi request reprint Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series
    Jennifer L Dotson
    Nationwide Children s Hospital, Columbus, Ohio 43205, USA
    Inflamm Bowel Dis 17:56-61. 2011
    ..Few data exist on the frequency, presentation, and appropriate treatment of pediatric patients with histoplasmosis on aTNF therapy...
  13. ncbi request reprint Workshop report: prevention of postoperative recurrence in Crohn's disease
    James Markowitz
    Division of Pediatric Gastroenterology, Schneider Chidren s Hospital, North Shore LIJ Health System, New Hyde Park, NY 11040, and University of Chicago, Chicago, IL, USA
    J Pediatr Gastroenterol Nutr 41:145-51. 2005